Navigation Links
ADVENTRX Announces Appointment of Senior Vice President, Commercial
Date:7/25/2011

SAN DIEGO, July 25, 2011 /PRNewswire/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced the appointment of Gregory D. Gorgas as Senior Vice President, Commercial.  

Mr. Gorgas brings more than 25 years of experience in drug product commercialization, with an emphasis in launching new products, building commercial infrastructure and leading start-up operations.  He was a key contributor to the blockbuster success of Rituxan® while at Biogen Idec, where most recently he led global marketing for the oncology franchise.  

"After consulting with ADVENTRX for over 18 months, I have deep familiarity with the company and its product candidates and believe in the promise and commercial potential of Exelbine," said Mr. Gorgas. "I'm thrilled to join the ADVENTRX team and look forward to making Exelbine available to patients, should it be approved."

"Greg's first-hand experience successfully launching four first-in-class products and strong relationships in the oncology community make him a great addition to our team.  Importantly, his understanding of the multi-source marketplace will prove valuable as we continue to prepare for the launch of Exelbine," said Brian M. Culley, Chief Executive Officer of ADVENTRX.  

About ADVENTRX Pharmaceuticals

ADVENTRX Pharmaceuticals is a specialty pharmaceutical company focused on acquiring, developing and commercializing proprietary product candidates.  The Company's current lead product candidates are Exelbine and ANX-514, novel emulsion formulations of currently marketed chemotherapy drugs, and ANX-188, a novel, purified, rheologic and antithrombotic compound initially being developed as a first-in-class treatment for pediatric patients with sickle cell disease in acute crisis.  More information can be found on the Company's web site at

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. ADVENTRX Pharmaceuticals Reports Second Quarter Financial Results
2. ADVENTRX to Hold Second Quarter Results and Business Update Conference Call on August 12
3. ADVENTRX Pharmaceuticals Announces Financing
4. ADVENTRX Pharmaceuticals Announces Plans for Remainder of 2009
5. ADVENTRX Pharmaceuticals Announces Closing of Financing
6. ADVENTRX Pharmaceuticals Announces Financing
7. ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results
8. ADVENTRX Announces Further Cost-Cutting Measures
9. ADVENTRX Provides Update on Strategic Transaction Process
10. ADVENTRX Announces Further Cost-Cutting Measures
11. ADVENTRX Exploring Strategic Options
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... 2014 ITRA Global, one of the ... commercial real estate, has further expanded its global reach ... and Brisbane, Western Australia, reports Mylinda Vick, CCIM, Chairman ... ITRA Global / ACORPP (Australian Corporate Property and Projects) ... providing property services to a wide range of clients ...
(Date:12/19/2014)... MA (PRWEB) December 19, 2014 Charm ... MRLAFMQ test for the Detection of Aflatoxin M1 in ... to receive independent third party validation. The peer reviewed ... Unit of the Institute for Agricultural and Fisheries Research ... Group. , Aflatoxin B1, the most toxic aflatoxin ...
(Date:12/19/2014)... Dec. 19, 2014  Roche (SIX: RO, ROG; OTCQX: ... Inc. (Bina), a privately held company based in ... Bina provides a big data platform for centralized ... data. Bina,s proprietary on-market Genomic Management Solution, Bina-GMS ... to perform fast and scalable analyses to maximize ...
(Date:12/19/2014)... DUBLIN , Dec. 19, 2014 Research ... announced the addition of the "Technology Innovations ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... Innovations in Smart Fabrics" offers a detailed assessment ... Key Findings: 1. ...
Breaking Biology Technology:ITRA Global Continues International Expansion in Perth and Brisbane, Australia 2Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1 2Roche acquires Bina Technologies and enters the genomic informatics market 2Roche acquires Bina Technologies and enters the genomic informatics market 3Technology Innovations in Smart Fabrics (Technical Insights) 2
... 40% this morning after it announced that Avastin, which many ... has been found to extend the lives of colon cancer ... and a regulatory decision buttressed the outlook for medicines that ... people ) is developing with smaller biotech partners. But ...
... Alex Bratton is determined to give heavy email users something they ... EmailRx , and a heavy email user, talks about the inspiration ... and the wireless world. , , WTN: How much email do ... receive around 1,000 messages a day from various email accounts with ...
... Valhalla, New York, has selected Verisis developed by Camtronics ... , for its new Cardiology Image and Information Management System. ... George E. Reed Heart Center , one of the most ... coast. The system will also extend into the Children's ...
Cached Biology Technology:Genentech's Winning Streak 2Genentech's Winning Streak 3WTN Interview: Alex Bratton: EmailRX's founder on viruses and spam 2WTN Interview: Alex Bratton: EmailRX's founder on viruses and spam 3NY Medical Center Selects Camtronics for Cardiovascular Image and Information Management 2
(Date:12/11/2014)... --Research and Markets , ... ) has announced the addition of the ... their offering. One major trend ... multimodal biometric systems. Multimodal biometric systems utilize more ... and identification purposes. This helps to reduce the ...
(Date:12/10/2014)...  Wake Forest Baptist Medical Center today announced plans for ... Medicine. Funding for this $50 million capital project is ... publicly launched next summer. The medical ... series R.J. Reynolds Tobacco Company complex, adjacent to 525@vine ... with plans to be ready to welcome medical students ...
(Date:12/5/2014)... 4, 2014  Tute Genomics, a leader in cloud-based ... Series A1 funding led by UK-based Eurovestech. Peak Ventures ... the investment round. "We are at a ... next-generation sequencing and seeks new approaches for the diagnosis, ... , MD MBA, and CEO of Tute Genomics. "One ...
Breaking Biology News(10 mins):Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3
... The average American child from age 8 to 18 ... have a TV in the bedroom and about one-third of ... that TV viewing time during childhood and adolescence continues into ... team from the Pennington Biomedical Research Center in Baton Rouge, ...
... on environmental issues such as climate change, deforestation, and ... But new research suggests that environmental messages framed in ... terms of fending off threats to the "purity" and ... to narrow the partisan gap. A study from ...
... deforestation and toxic waste, the assumption has been that conservative ... the University of California, Berkeley, suggests that such viewpoints can ... to be better stewards of the land are couched in ... of Earth and our bodies. A UC Berkeley study ...
Cached Biology News:Bedroom TV viewing increases risk of obesity in children 2Messages that speak to conservatives' morals narrow partisan gap on environment 2Messages that speak to conservatives' morals narrow partisan gap on environment 3Conservatives can be persuaded to care more about the environment 2Conservatives can be persuaded to care more about the environment 3
Mouse monoclonal antibody to PPP2R2C - protein phosphatase 2 (formerly 2A), regulatory subunit B (PR 52), gamma isoform...
Mouse monoclonal antibody to PARK2 - Parkinson disease (autosomal recessive, juvenile) 2, parkin...
... used to quantitate double-stranded DNA (dsDNA) in solution, ... With this kit, DNA is stained with Hoechst ... VersaFluor or other fluorometer. The kit quantitates dsDNA ... to 5 micrograms per ml and contains Hoechst ...
... combines enterprise-scale sequence analysis software with the DeCypher ... With DeCypher, you can perform searches like these ... NCBI NT database in under 6 days ... DNA Use HMM analysis to compare ...
Biology Products: